Combined effects of systolic blood pressure and total cholesterol on cardiovascular disease risk

Circulation

Volumn 112, Issue 22, 2005, Pages 3373-3374

  Lewington, Sarah ^a   Clarke, Robert ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Blood pressure; Cardiovascular diseases; Cholesterol; Editorials; Meta analysis

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ASIAN; AUSTRALIA; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; EDITORIAL; FATALITY; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; NEW ZEALAND; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; BLOOD; BLOOD PRESSURE; META ANALYSIS; NOTE; PHYSIOLOGY; RISK FACTOR; SYSTOLE;

BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; HUMANS; META-ANALYSIS; RISK FACTORS; SYSTOLE;

EID: 33644876389     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.581934     Document Type: Editorial

References (20)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349:1269-1276.
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498-1504.
3. Ezzati M, Vander Hoorn S, Rodgers A, Lopez AD, Mathers CD, Murray CJ; the Comparative Risk Assessment Collaborating Group. Estimates of global and regional potential health gains from reducing multiple selected major risk factors. Lancet. 2003;362:271-280.
4. Asia Pacific Cohort Studies Collaboration. Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region. Circulation. 2005;112:3384-3390.
5. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Arch Intern Med. 1992;152:56-64.
6. Lowe LP, Greenland P, Ruth KJ, Dyer AR, Stamler R, Stamler J. Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men. Arch Intern Med. 1998;158:2007-2014.
7. Thomas F, Bean K, Guize L, Quentzel S, Argyriadis P, Benetos A. Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women. Eur Heart J. 2002;23:528-535.
8. Wald NJ, Law M. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003;326:1419-1424.
9. Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, Peto R. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150:341-353.
10. Clarke R, Lewington S, Youngman L, Sherliker P, Peto P, Collins R. Underestimation of the importance of blood pressure and cholesterol for coronary heart disease mortality in old age. Eur Heart J. 2002;23:286-293.
11. Rosner B, Spiegelman D, Willett WC. Correction of logistic regression relative risk estimates and confidence intervals for measurement error: the case of multiple covariates measured with error. Am J Epidemiol. 1990;132:734-745.
12. Cholesterol Treatment Trialists' (CTT) Collaboration. Prospective meta-analysis of individual data from 90 056 participants in randomized trials of cholesterol-lowering treatment. Lancet. 2005;366:1267-1278.
13. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003;362:1527-1535.
14. Sever P, Dahlöf B, Poulter N, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen S, Kristinsson A, Mclnnes G, Mehlsen J, Nieminen M, O'Brien E, Östergren J; ASCOT Investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003;361:1149-1158.
15. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data from one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
16. Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21:707-716.
17. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 1994;308:367-372.
18. Asia Pacific Cohort Studies Collaboration. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol. 2003;32:563-572.
19. Emberson J, Whincup P, Morris R, Walker M, Ebrahim S. Evaluating the impact of population and high risk strategies for the primary prevention of cardiovascular disease. Eur Heart J. 2004;25:484-491.
20. Strachan D, Rose G. Strategies of prevention revisited: effects of imprecise measurement of risk factors on the evaluation of "high-risk" and "population-based" approaches to prevention of cardiovascular disease. J Clin Epidemiol. 1991;44:1187-1196.